Almirall, S.A. (BME:ALM)

Market Cap	2.31B
Revenue (ttm)	990.63M
Net Income (ttm)	10.15M
Shares Out	213.47M
EPS (ttm)	0.05
PE Ratio	225.05
Forward PE	28.80
Dividend	0.19 (1.94%)
Ex-Dividend Date	May 17, 2024

Volume	479,158
Average Volume	116,504
Open	10.34
Previous Close	9.80
Day's Range	10.26 - 10.94
52-Week Range	8.03 - 10.94
Beta	0.26
RSI	69.31
Earnings Date	May 12, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM